Alzheimer’s disease (AD) is a progressive neurodegenerative disorder characterized by memory impairment, cognitive decline, and behavioral alterations. It is the most common form of dementia among older adults and represents a major global health, social, and economic burden. Current pharmacological interventions primarily provide symptomatic relief and have limited efficacy in preventing or reversing the underlying disease pathology, highlighting the need for alternative and innovative therapeutic approaches. Natural compounds with neuroprotective properties have demonstrated considerable potential for targeting multiple pathological mechanisms associated with AD. Phytochemicals, including polyphenols, alkaloids, terpenoids, flavonoids, and other bioactive constituents widely found in fruits, vegetables, herbs, and medicinal plants, exhibit diverse and complementary mechanisms of action. These include inhibition of acetylcholinesterase (AChE), suppression of amyloid-β aggregation, antioxidant and anti-inflammatory activities, and modulation of key signaling pathways involved in neuronal survival and synaptic plasticity. Ginsenosides derived from ginseng, resveratrol from grapes, curcumin from turmeric, and epigallocatechin gallate (EGCG) from green tea are among the most extensively studied phytochemicals and have demonstrated promising neuroprotective effects in numerous preclinical models. These compounds may exert multitarget effects against several pathological hallmarks of AD, offering potential advantages over conventional pharmacological approaches that primarily target individual disease mechanisms. This review provides a comprehensive overview of the therapeutic potential and mechanisms of action of major phytochemicals, with particular emphasis on their prospective applications in the development of novel therapeutic agents and evidence-based preventive strategies for AD.